MARKET

BLACR

Bellevue Life Sciences Acquisition Rights Exp 9 Feb 2028
BLACR
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-
-
0.0623
-
OSR Holdings inks VXM01 global license deal with BCM Europe worth up to $815 million
PUBT · 1h ago
OSR Holdings appoints Yeiseok Kim as chief operating officer effective April 16
PUBT · 6d ago
OSR Holdings COO Yeiseok Kim files initial beneficial ownership statement
PUBT · 04/16 14:10
OSR Holdings issues $1.06 million convertible note to retire $2.02 million warrants
Reuters · 04/09 13:16
OSR Holdings amends 8-K, corrects VXM01 license agreement exhibit share price
Reuters · 04/03 10:15
OSR HOLDINGS INC - TO PROVIDE VAXIMM WITH UP TO $30 MLN DEVELOPMENT FINANCING FACILITY - SEC FILING
Reuters · 04/02 19:48
OSR Holdings signs term sheet for VXM01 license with up to $815 million milestones
Reuters · 04/02 19:46
OSR Holdings FY25 operating loss widens 57% to $18.3 million; net sales fall 18% to $2.9 million
Reuters · 03/31 20:12
More

Webull offers Bellevue Life Sciences Acquisition Rights Exp 9 Feb 2028 stock information, including NASDAQ: BLACR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BLACR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BLACR stock methods without spending real money on the virtual paper trading platform.